Introduction
The global oral thin films market is projected to reach USD 5.64 billion by 2031, growing at a CAGR of 9.35%, signaling unprecedented demand for advanced oral dissolving film (ODF) manufacturing equipment.\[1\] As pharmaceutical manufacturers seek innovative dosage forms that improve patient compliance and bioavailability, understanding the technical differences between ODF machinery systems has become critical for investment decisions.
Aligned Machinery leads the pharmaceutical equipment industry with comprehensive ODF production solutions spanning pilot-scale testing to full commercial-scale manufacturing. This comparison examines how mainstream oral film machinery operates, their core technical principles, and performance capabilities to help manufacturers select the optimal equipment for their production needs.
Quick Answer
Oral dissolving film machinery operates primarily through solvent-casting or hot-melt extrusion methods, with solvent-casting systems dominating pharmaceutical applications due to their suitability for thermolabile drugs and precise thickness control. Aligned Machinery offers integrated casting systems that combine solution preparation, deaeration, casting, drying, and cutting in continuous production lines capable of producing films from 120mm to 340mm width with thickness precision of ±5%.
Working Principle Comparison
| Manufacturing Method | Temperature Range | Drug Compatibility | Production Speed | Equipment Complexity | Best For |
| Solvent Casting | 40-70°C | Thermolabile & thermostable | Moderate | Medium | Pharmaceutical ODFs |
| Hot-Melt Extrusion | 120-180°C | Thermostable only | High | High | Nutraceuticals |
| Semisolid Casting | 50-80°C | pH-sensitive drugs | Low | Low | R&D applications |
How Solvent-Casting Machinery Works
Solvent-casting machinery transforms liquid pharmaceutical formulations into uniform thin films through a controlled five-stage process: solution preparation, deaeration, precision casting, controlled drying, and automated cutting.\[2\]
Stage 1: Solution Preparation
The process begins with dissolving water-soluble film-forming polymers such as hydroxypropylmethyl cellulose (HPMC), hydroxypropyl cellulose (HPC), or pullulan in purified water or aqueous-alcohol mixtures. The active pharmaceutical ingredient (API) is dissolved separately and combined with the polymer solution along with plasticizers, sweetening agents, and flavoring compounds to create a homogeneous, viscous casting solution.
Aligned Machinery’s preparation tank systems feature precision temperature control and high-shear mixing capabilities that ensure complete polymer hydration and API dissolution, critical for uniform film properties.
Stage 2: Deaeration
Air bubbles trapped during mixing must be removed to prevent defects in the final film. Vacuum deaeration reduces air content to below 0.5% by volume, ensuring uniform film thickness and mechanical properties.\[2\] This step directly impacts film appearance, dissolution characteristics, and content uniformity.
Stage 3: Precision Casting
The deaerated solution is pumped through a precision coating head onto a moving substrate—typically stainless steel, Teflon-coated, or polyester backing. The coating head gap determines wet film thickness, which is precisely controlled through servo-driven doctor blades or slot-die systems.
Aligned Machinery’s commercial-scale equipment employs advanced slot-die coating technology with gap adjustment precision of ±0.01mm, enabling consistent film thickness across widths up to 340mm. This precision translates directly to dose uniformity—a critical quality attribute for pharmaceutical products.
Stage 4: Controlled Drying
Drying is the most critical stage, requiring precise temperature and airflow control to remove solvents without degrading heat-sensitive APIs or causing film defects.\[2\] Multi-zone drying tunnels with independent temperature control in each zone allow gradual solvent evaporation, preventing surface skinning, bubble formation, or curling.
Typical drying profiles range from 40°C at entry zones to 60-70°C in final zones, with residence times of 3-8 minutes depending on film thickness and solvent composition. Aligned Machinery integrates infrared and hot-air combination drying systems that reduce energy consumption by 25% compared to conventional hot-air-only systems while maintaining gentle drying conditions for sensitive formulations.
Stage 5: Automated Cutting & Packaging
Once dried, the continuous film is slit into ribbons and cross-cut into individual doses using precision rotary or ultrasonic cutting systems. Vision inspection systems detect defects and reject non-conforming units before packaging.
Aligned Machinery’s integrated cutting and packaging systems achieve cutting speeds up to 300 cuts per minute with positional accuracy of ±0.5mm, ensuring consistent dose size and minimizing material waste.
Hot-Melt Extrusion Systems
Hot-melt extrusion (HME) eliminates solvents entirely by melting thermoplastic polymers with APIs and extruding the molten mass through a die to form films.\[2\] This method suits thermostable drugs and offers advantages including:
• No solvent residues requiring validation
• Continuous processing with fewer steps
• Enhanced bioavailability for poorly soluble drugs through amorphous solid dispersion formation
• Reduced environmental impact
However, HME systems require higher capital investment, operate at temperatures typically between 120-180°C (limiting API selection), and demand specialized polymer grades designed for extrusion processing. The high processing temperatures make HME unsuitable for the majority of pharmaceutical APIs, which explains why solvent-casting remains the dominant method for pharmaceutical ODF production.
Performance Comparison: Key Specifications
| Specification | Lab-Scale Systems | Mid-Scale Systems | Commercial Systems |
| Film Width | 120-160mm | 200-260mm | 340mm+ |
| Production Speed | 0.5-2 m/min | 2-5 m/min | 5-15 m/min |
| Thickness Range | 20-200 μm | 30-150 μm | 40-120 μm |
| Thickness Precision | ±8% | ±6% | ±5% |
| Output Capacity | 5-20 kg/day | 50-150 kg/day | 300-1000 kg/day |
| Drying Zones | 2-3 | 3-5 | 5-8 |
| Automation Level | Semi-automatic | Automatic | Fully automatic |
Aligned Machinery’s pilot-scale equipment (ZM-120, ZM-160 series) provides pharmaceutical R&D teams with scalable platforms for formulation development that translate directly to commercial production parameters, reducing scale-up risks and accelerating time-to-market.
Critical Performance Factors
Film Thickness Uniformity
Thickness uniformity directly impacts dose accuracy—the most critical quality attribute for pharmaceutical films. Modern pharmaceutical ODF machinery must achieve thickness variation coefficients below 5% across the entire film width. This requires:
• Precision-machined coating heads with flatness tolerances under 10 μm
• Real-time thickness monitoring using laser or beta-ray gauges
• Closed-loop feedback control adjusting coating gap in real-time
• Vibration-isolated frames preventing mechanical disturbances
Aligned Machinery incorporates laser thickness measurement systems on commercial lines, enabling continuous quality monitoring and automatic rejection of out-of-specification sections.
Drying Efficiency & Energy Consumption
Drying accounts for 60-70% of total energy consumption in ODF production. Advanced multi-zone drying systems with heat recovery can reduce energy costs by 30-40% while improving product quality through gentler, more uniform drying.
Key technologies include:
• Infrared pre-drying zones for rapid initial solvent evaporation
• Recirculating hot-air systems with heat exchangers recovering exhaust heat
• Humidity-controlled exhaust preventing condensation and cross-contamination
• Zone-specific temperature profiles optimized for different formulation types
Content Uniformity & Dose Accuracy
Content uniformity—ensuring each film unit contains the precise API dose—depends on solution homogeneity, casting precision, and cutting accuracy. Pharmaceutical regulations typically require content uniformity within 85-115% of label claim with acceptance values meeting pharmacopoeial standards.
Aligned Machinery achieves superior content uniformity through:
• High-shear mixing systems ensuring complete API dispersion
• Inline homogenizers preventing API settling during casting
• Precision metering pumps maintaining consistent solution flow
• Vision-guided cutting systems ensuring accurate unit dimensions
Scale-Up Considerations
Successful scale-up from lab to commercial production requires maintaining critical process parameters including shear rate during mixing, coating gap-to-viscosity ratio, drying rate profiles, and web tension.\[2\]
Common scale-up challenges include:
1. Solution stability: Larger batch sizes may exhibit different settling or gelation behavior
2. Drying uniformity: Wider films require more sophisticated air distribution systems
3. Web handling: Higher speeds demand advanced tension control preventing wrinkles or tears
4. Yield optimization: Minimizing edge trim and startup waste becomes more critical at commercial scale
Aligned Machinery has supported over 50 successful scale-up projects across North America, Europe, and Asia, providing technical guidance throughout the formulation transfer process and ensuring first-time-right commercial production startup.
Integrated vs. Modular Systems
Manufacturers face a strategic choice between integrated all-in-one systems and modular configurations:
Integrated Systems (like Aligned Machinery’s ZMB-360 Series) combine casting, drying, cutting, and packaging in a single continuous line. Benefits include:
• Reduced floor space requirements (30-40% less than modular)
• Simplified material handling and reduced contamination risk
• Single-vendor responsibility for equipment performance
• Optimized process integration and control
Modular Systems connect separate preparation, casting, drying, and packaging units. Advantages include:
• Flexibility to upgrade individual modules independently
• Ability to run multiple formulations with shared preparation equipment
• Easier validation with clear process stage boundaries
• Potential for higher overall equipment effectiveness (OEE) through parallel processing
For most pharmaceutical manufacturers producing multiple ODF products, Aligned Machinery recommends integrated systems for primary products with modular preparation tanks serving multiple casting lines—balancing efficiency with flexibility.
Quality Control & Process Analytical Technology
Modern ODF machinery incorporates Process Analytical Technology (PAT) enabling real-time quality monitoring and control rather than relying solely on end-product testing.
Critical PAT tools include:
• Inline viscosity monitoring detecting solution preparation issues before casting
• Laser thickness gauges providing continuous thickness profiles across film width
• Moisture analyzers optimizing drying endpoint determination
• Vision inspection systems detecting visual defects, foreign particles, and cutting accuracy
• Weight check systems verifying individual dose weight as a surrogate for content
Aligned Machinery’s commercial systems feature integrated data acquisition systems collecting process parameters and quality measurements, supporting regulatory requirements for electronic batch records and enabling advanced statistical process control.
Maintenance & Operational Considerations
Total cost of ownership extends beyond purchase price to include maintenance requirements, consumable costs, and operational efficiency.
Key operational factors:
Cleaning & Changeover
ODF equipment requires frequent cleaning between batches or product changes. Quick-change coating heads and tool-free disassembly can reduce changeover time from 4-6 hours to under 2 hours, significantly improving equipment utilization.
Aligned Machinery designs equipment with sanitary construction principles including:
• Smooth, crevice-free surfaces preventing residue accumulation
• Quick-disconnect fittings for rapid component removal
• Clean-in-place (CIP) capability for solution contact parts
• Modular construction allowing offline cleaning of critical components
Substrate & Consumables
Continuous casting systems require backing substrates—either disposable polyester films or reusable stainless steel belts. Stainless steel belts offer 3-5 year service life and superior flatness but require investment in belt cleaning and reconditioning equipment. Disposable substrates eliminate cleaning but incur ongoing material costs of $0.15-0.30 per meter depending on width and specification.
Spare Parts & Technical Support
Critical spare parts inventory should include coating blades, pump diaphragms, cutting blades, and sensor components. Aligned Machinery provides comprehensive warranty coverage, minimizing production downtime.
FAQ
What is the main difference between solvent-casting and hot-melt extrusion for ODF production?
Solvent-casting dissolves polymers and APIs in liquid solvents, casts the solution into films, and removes solvents through drying. Hot-melt extrusion melts thermoplastic polymers with APIs at high temperatures and extrudes the molten mass into films without solvents. Aligned Machinery specializes in solvent-casting systems because they accommodate both thermolabile and thermostable drugs, which is essential for pharmaceutical applications where most APIs cannot withstand the 120-180°C temperatures required for hot-melt extrusion.\[2\]
How do I determine the right scale of ODF machinery for my production needs?
Select equipment scale based on your target annual production volume, number of products, and batch size requirements. Lab-scale systems (120-160mm width, 5-20 kg/day capacity) suit R&D and clinical trial material production. Mid-scale equipment (200-260mm width, 50-150 kg/day) serves regional markets or multiple low-volume products. Commercial systems (340mm+ width, 300-1000 kg/day) support national or international markets for established products. Aligned Machinery offers equipment across all scales with consistent design principles enabling smooth technology transfer between scales.
What film thickness precision is required for pharmaceutical ODF products?
Pharmaceutical regulatory agencies typically require thickness uniformity with relative standard deviation (RSD) below 5-6% to ensure dose uniformity. This translates to thickness precision of ±5% for commercial production. Aligned Machinery’s commercial casting systems achieve ±5% thickness precision through precision-machined coating heads, real-time laser thickness monitoring, and closed-loop gap control, meeting pharmaceutical quality standards while maximizing yield.
Can the same ODF machinery handle different formulations and film sizes?
Yes, modern ODF equipment features adjustable parameters accommodating different formulations and sizes. Coating gap adjustment enables thickness ranges from 40-200 μm wet thickness. Slitting and cutting systems adjust to produce films from 10x10mm to 50x50mm or custom sizes. However, formulation changes may require different drying profiles, and significant viscosity differences may necessitate coating head modifications. Aligned Machinery provides formulation development support and equipment configuration recommendations to maximize versatility while maintaining quality standards.
What are the typical lead times and installation requirements for commercial ODF production lines?
Commercial ODF production lines typically require 6-9 months from order to installation completion, including 3-4 months for manufacturing, 1-2 months for factory acceptance testing (FAT), shipping, and 1-2 months for site installation and commissioning. Installation requires controlled-environment space (typically 100-150 m² for integrated commercial lines), three-phase electrical power (typically 60-100 kW), compressed air supply (6-8 bar, 50-100 CFM), and appropriate HVAC maintaining temperature and humidity control. Aligned Machinery provides comprehensive installation, commissioning, and operator training services ensuring successful production startup and regulatory readiness.
Conclusion
Selecting optimal oral dissolving film machinery requires balancing technical capabilities, scalability, operational efficiency, and total cost of ownership. Solvent-casting systems dominate pharmaceutical ODF production due to their compatibility with thermolabile drugs, precise thickness control, and proven regulatory acceptance. Key performance factors include film thickness uniformity (target ±5%), drying efficiency, content uniformity, and automation level.
Aligned Machinery delivers comprehensive ODF manufacturing solutions from lab-scale formulation development through commercial-scale production, backed by extensive case study experience across North America, Europe, and Asia. Our integrated approach combines precision engineering, process expertise, and ongoing technical support to ensure successful ODF product commercialization.
Ready to discuss your ODF production requirements? Contact Aligned Machinery’s technical team for a confidential consultation on equipment selection, formulation development support, and project planning tailored to your specific needs.
References
\[1\] Mordor Intelligence, “Oral Thin Films Market Size, Trends & Forecast Report,” 2026. “The Oral Thin Films Market worth USD 3.61 billion in 2026 is growing at a CAGR of 9.35% to reach USD 5.64 billion by 2031.” https://www.mordorintelligence.com/industry-reports/oral-thin-films-market
\[2\] Pharmaceutical Technology, “Manufacturing Techniques of Orally Dissolving Films,” 2011. “The manufacture of orally dissolving films is done by various methods such as solvent casting, hot-melt extrusion, semisolid casting, solid-dispersion extrusion, and rolling.” https://www.pharmtech.com/view/manufacturing-techniques-orally-dissolving-films
\[3\] Aligned Machinery, “Oral Dissolving Film Making Machine,” 2026. “Aligned Technology offers comprehensive ODF production solutions from pilot-scale testing to full commercial-scale manufacturing and packaging.” https://www.odfsolution.com/oral-dissolving-film-making-machine/
Post time: May-22-2026